Search Within

Heiko Schoder

  1. "Medical Physics"
Formats
  1. Journal Article (77)
  2. Meeting Abstract (58)
  3. Editorial (3)
  4. Book Section (2)
  5. Conference Paper (1)
  6. Guidelines (1)
  7. Miscellaneous (1)
  8. Review (1)
Groups
  1. Medical Physics (144)
  2. Molecular Imaging and Therapy Service (144)
  3. Radiology, Department of (144)
  4. GSK Faculty (68)
  5. Sloan Kettering Institute Postdocs (61)
  6. Department of Medicine (55)

More Groups

People
  1. John Humm (96)
  2. Nancy Lee (46)
  3. Steven Larson (46)
  4. Sadek Nehmeh (32)
  5. Milan Grkovski (31)
  6. Pat Zanzonico (23)

More People

Years
  1. 2025 (4)
  2. 2024 (11)
  3. 2023 (9)
  4. 2022 (8)
  5. 2021 (8)
  6. 2020 (10)

More Years

Publications
  1. Journal of Nuclear Medicine (41)
  2. International Journal of Radiation Oncology, Biology, Physics (25)
  3. Journal of Clinical Oncology (14)
  4. European Journal of Nuclear Medicine and Molecular Imaging (11)
  5. Medical Physics (11)
  6. EJNMMI Research (5)

More Publications

Publishers
  1. Society of Nuclear Medicine (41)
  2. Elsevier Inc. (29)
  3. Springer (18)
  4. American Society of Clinical Oncology (14)
  5. American Association of Physicists in Medicine (11)
  6. American Association for Cancer Research (4)

More Publishers

Results (144)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
    Journal Article

    Phillips, E.; Penate-Medina, O.; Zanzonico, P. B.; Carvajal, R. D.; Mohan, P.; Ye, Y.; Humm, J.; Gonen, M.; Kalaigian, H.; Schöder, H.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Riviere, I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib
    Meeting Abstract

    Fox, J. J.; Haupt, E. C.; Humm, J.; Autio, K. A.; Rathkopf, D. E.; Vargas, H. A.; Schöder, H.; Hricak, H.; Larson, S. M.; Scher, H. I.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Predictive modeling of outcomes following definitive chemoradiation therapy for oropharyngeal cancer based on FDG-PET image characteristics
    Meeting Abstract

    Folkert, M. R.; Oh, J. H.; Setton, J.; Apte, A. P.; Thorstad, W. L.; Schoder, H.; Lee, N. Y.; Deasy, J. O.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • Pilot study of PET imaging of (124)I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer
    Journal Article

    O'Donoghue, J. A.; Guillem, J. G.; Schoder, H.; Lee, N. Y.; Divgi, C. R.; Ruby, J. A.; Humm, J. L.; Lee-Kong, S. A.; Burnazi, E. M.; Cai, S.; more...
    EJNMMI Research (2013)

    Fulltext@MSK | Save
  • Split-dose technique for FDG PET/CT-guided percutaneous ablation: A method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness
    Journal Article

    Ryan, E. R.; Sofocleous, C. T.; Schoder, H.; Carrasquillo, J. A.; Nehmeh, S.; Larson, S. M.; Thornton, R.; Siegelbaum, R. H.; Erinjeri, J. P.; Solomon, S. B.
    Radiology (2013)

    Fulltext@MSK | Save
  • 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Jia, X.; Heller, G.; Schoder, H.; Humm, J.; Haupt, E. C.; Schneider, C.; Scher, H. I.; Larson, S. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save